Every material Form 8-K Exelon filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Exelon Corporation completed the sale of $1 billion in 3.25% convertible senior notes due March 15, 2029, including the full $100 million option, in a private offering. The company estimates net proceeds of about $987.5 million, which it intends to use to repay or refinance debt or for general corporate purposes, and the notes can be converted into cash, shares, or a combination of both. For shareholders, the deal adds debt and could lead to new shares if holders convert, with the initial conversion price set at about $57.11 per share, a 25% premium to the December 1, 2025 closing price.
Notes total $1 billion, including the $100 million option exercised in full, and mature March 15, 2029
Interest of 3.25% per year is payable semiannually, starting September 15, 2026
Initial conversion price is about $57.11 per share, a premium of about 25% over the December 1, 2025 last reported sale price
Estimated net proceeds are about $987.5 million before other offering expenses
Exelon said Executive Vice President David Glockner, who oversees compliance, audit and risk, will leave the company effective January 1, 2026, with severance under the Senior Management Severance Plan. Responsibilities will shift to two current executives: CFO Jeanne Jones takes audit and risk, and Chief Legal Officer Colette Honorable takes compliance.
David Glockner, EVP Compliance, Audit and Risk, departs effective January 1, 2026
Glockner to receive benefits under the Senior Management Severance Plan for a termination other than for cause
Jeanne Jones to become EVP, Chief Finance Officer, Audit and Risk, in an expanded role
Colette Honorable to become EVP, Chief Legal Officer, Compliance and Corporate Secretary, in an expanded role
Exelon reported third quarter 2025 results on November 4, 2025, with GAAP net income of $875 million, or $0.86 per share, up from $707 million, or $0.70 per share, a year earlier. The company reaffirmed its full-year 2025 adjusted operating earnings guidance of $2.64 to $2.74 per share, which matters to shareholders because it signals the company expects results to stay on its planned path.
Q3 2025 adjusted operating earnings were $0.86 per share, compared with $0.71 per share in Q3 2024
Q3 2025 operating revenues were $6,705 million, compared with $6,154 million in Q3 2024
Full-year 2025 adjusted operating earnings guidance affirmed at $2.64 to $2.74 per share
Quarterly dividend of $0.40 per share declared October 29, 2025, payable December 15, 2025 to holders of record on November 10, 2025
Exelon reported second-quarter 2025 results on July 31, 2025. Revenue rose to $5,427 million from $5,361 million, but adjusted operating earnings fell to $0.39 per share from $0.47 a year earlier, and the company affirmed its full-year 2025 adjusted EPS guidance of $2.64-$2.74.
Adjusted operating EPS was $0.39 versus $0.47 a year earlier; GAAP EPS was $0.39 versus $0.45.
Operating revenues were $5,427 million versus $5,361 million; GAAP net income was $391 million versus $448 million.
Full-year 2025 adjusted operating EPS guidance of $2.64-$2.74 was affirmed; PECO storm outages peaked above 325,000 customers.
The board declared a $0.40 quarterly dividend on July 29, 2025, payable September 15, 2025.
On May 2, 2025, Exelon entered into an Equity Distribution Agreement creating an at-the-market program to sell common stock with an aggregate gross sales price of up to $2.5 billion. The company has no obligation to sell any shares and may suspend or terminate the program at any time, and it expects to use any net proceeds for general corporate purposes, including repaying debt. Shares sold would dilute existing holders, so shareholders should note the potential increase in outstanding shares.
Program size: aggregate gross sales price of up to $2,500,000,000 across sales agents and forward sellers
Company expects proceeds from physical settlement of forward sale agreements, with use of proceeds for general corporate purposes including debt repayment
Shares offered under Form S-3 Registration Statement No. 333-284911
Exelon reported first-quarter 2025 GAAP net income of $908 million, or $0.90 per share, up from $658 million, or $0.66 per share, a year earlier. Adjusted operating earnings rose to $0.92 per share from $0.68, and the company affirmed its full-year 2025 adjusted operating earnings guidance of $2.64 to $2.74 per share.
GAAP net income of $908 million ($0.90 per share) versus $658 million ($0.66 per share) in Q1 2024
Adjusted operating earnings of $0.92 per share versus $0.68 per share in Q1 2024
Full-year 2025 adjusted operating earnings guidance of $2.64 to $2.74 per share affirmed
Quarterly dividend of $0.40 per share declared April 29, 2025, payable June 13, 2025
Exelon's Board appointed David DeWalt as an independent director effective March 10, 2025. DeWalt is founder and CEO of venture capital and cybersecurity firm NightDragon, and the company says his expertise will help oversee safety of operations and customer data as it upgrades systems.
David DeWalt appointed to Exelon Board of Directors effective March 10, 2025
Committee assignments have not yet been determined
DeWalt will receive Exelon's standard director compensation, as disclosed in the March 20, 2024 proxy statement
DeWalt previously led cybersecurity firms FireEye and McAfee
Exelon sold $1.0 billion of senior notes on February 21, 2025, split into $500 million of 5.125% notes due 2031 and $500 million of 5.875% notes due 2055. Part of the proceeds, with available cash, will repay $464 million of commercial paper borrowings that carried a weighted average rate of 4.537% as of February 11, 2025, and the rest will fund general corporate purposes. The filing describes a financing transaction that adds long-term debt rather than a change to operations or earnings.
Notes: $500 million of 5.125% due March 15, 2031 and $500 million of 5.875% due March 15, 2055
Interest paid semi-annually on March 15 and September 15, starting September 15, 2025
$464 million of proceeds plus cash on hand to repay commercial paper at about 4.537% weighted average rate
Exelon reported fourth-quarter 2024 adjusted operating earnings of $0.64 per share, up from $0.60 a year earlier, and full-year adjusted earnings of $2.50 per share, up from $2.38. The company introduced 2025 adjusted earnings guidance of $2.64-$2.74 per share and raised its four-year capital plan to $38 billion, which includes $1.4 billion of additional equity.
Q4 2024 GAAP net income of $0.64 per share, up from $0.62; adjusted operating earnings of $0.64 per share, up from $0.60
Full-year 2024 adjusted operating earnings of $2.50 per share, up from $2.38 in 2023
2025 adjusted operating earnings guidance range of $2.64-$2.74 per share
Capital expenditure plan of $38 billion over four years, up 10% from the prior plan, with $1.4 billion of additional equity
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Exelon filing is on SEC EDGAR ↗. 8-K briefs of other companies →